CNPY3 and prostate carcinoma: This inhibits lactylation at the K215 and K224 sites of CNPY3 and promotes the lysosome-dependent CatB/caspase 1/GSDMD pyroptotic pathway, inducing pyroptosis in DU145 cells and suppressing prostate cancer progression 26.